What the evidence has to support
Four questions decide whether evidence is sufficient. Most evidence problems trace back to one of them.
The intended purpose
Evidence is judged against what the device is intended to do, for whom and in what setting. A vague intended purpose makes it impossible to say when the evidence is enough.
The claims
Every clinical or performance claim in the labelling, instructions and marketing needs evidence behind it. Narrowing a claim can be cheaper than generating evidence for it.
The population
Data from one population does not automatically carry over to another. The evidence needs to represent the patients, users and conditions the product is intended for.
The regulatory pathway
Classification and conformity assessment route shape what evidence is expected and how it will be assessed. MDR clinical evaluation and IVDR performance evaluation are built differently.
Questions we work on
- How many patients or samples do we need?
- Can we use retrospective data?
- Do we need an external validation study?
- Are we validating the right thing?
- Are we doing more than the regulation actually requires?
- Can one study support more than one market?
- Will an EU claim create problems for a later FDA pathway?
Services for evidence and validation
Clinical and performance evidence
What evidence do we actually need to support our medical device or IVD?
AI validation and evidence
How do we demonstrate that our AI-enabled medical device works reliably and safely for its intended medical use?
Notified Body readiness
Are we ready to submit to a Notified Body?
Primary regulatory sources
Last reviewed: October 2026
- Regulation (EU) 2017/745 on medical devices https://eur-lex.europa.eu/eli/reg/2017/745/oj
- Regulation (EU) 2017/746 on in vitro diagnostic medical devices https://eur-lex.europa.eu/eli/reg/2017/746/oj
Have an evidence question?
Tell us what the product is for, what evidence you already have and the decision you need to make.
We start from what you already have, and say plainly if the existing evidence is enough.
The first conversation is free and carries no commitment.
